These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32527052)

  • 1. Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-resistance by Feature Extraction of Gray Level Co-occurrence Matrix Using Optical Images.
    Huang CL; Lian MJ; Wu YH; Chen WM; Chiu WT
    Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32527052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texture feature extraction of gray-level co-occurrence matrix for metastatic cancer cells using scanned laser pico-projection images.
    Lian MJ; Huang CL
    Lasers Med Sci; 2019 Sep; 34(7):1503-1508. PubMed ID: 30043142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study for Texture Feature Extraction of High-Resolution Satellite Images Based on a Direction Measure and Gray Level Co-Occurrence Matrix Fusion Algorithm.
    Zhang X; Cui J; Wang W; Lin C
    Sensors (Basel); 2017 Jun; 17(7):. PubMed ID: 28640181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.
    Zou W; Ma X; Yang H; Hua W; Chen B; Cai G
    Exp Biol Med (Maywood); 2017 Mar; 242(5):497-504. PubMed ID: 28056551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Gray Level Co-Occurrence Matrix-Based Texture Features of Magnetic Resonance Images for Glioblastoma Multiform Patients' Treatment Response Assessment.
    Alibabaei S; Rahmani M; Tahmasbi M; Tahmasebi Birgani MJ; Razmjoo S
    J Med Signals Sens; 2023; 13(4):261-271. PubMed ID: 37809020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.
    Schilder RJ; Hall L; Monks A; Handel LM; Fornace AJ; Ozols RF; Fojo AT; Hamilton TC
    Int J Cancer; 1990 Mar; 45(3):416-22. PubMed ID: 2307530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Distinction of Morphological Characteristics of White Blood Cells in Peripheral Blood Through Texture Analysis Using Gray Level Co-Occurrence Matrix.
    Yamamoto M; Kono K; Kuroki M; Murakami S; Hayata R; Nanato K; Shao M; Miwa K; Tsutsumi Y; Okada K; Kaga S; Masauzi N
    Clin Lab; 2017 Nov; 63(11):1851-1868. PubMed ID: 29226651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells.
    Schneiderman D; Kim JM; Senterman M; Tsang BK
    Apoptosis; 1999 Aug; 4(4):271-81. PubMed ID: 14692397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
    Yang X; Zhang Q; Yang X; Zhao M; Yang T; Yao A; Tian X
    Biochem Biophys Res Commun; 2019 Apr; 511(4):719-724. PubMed ID: 30827507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Solár P; Sytkowski AJ
    Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.
    Amini-Farsani Z; Sangtarash MH; Shamsara M; Teimori H
    Cytotechnology; 2018 Feb; 70(1):203-213. PubMed ID: 28887606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
    Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
    Lee HS; Hong H; Jung DC; Park S; Kim J
    Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of vocal-fold mucosal irregularities using GLCM-based texture analysis.
    Song CI; Ryu CH; Choi SH; Roh JL; Nam SY; Kim SY
    Laryngoscope; 2013 Nov; 123(11):E45-50. PubMed ID: 23686645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray level co-occurrence matrix (GLCM) texture based crop classification using low altitude remote sensing platforms.
    Iqbal N; Mumtaz R; Shafi U; Zaidi SMH
    PeerJ Comput Sci; 2021; 7():e536. PubMed ID: 34141878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.
    Perego P; Romanelli S; Carenini N; Magnani I; Leone R; Bonetti A; Paolicchi A; Zunino F
    Ann Oncol; 1998 Apr; 9(4):423-30. PubMed ID: 9636834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel system in vitro of classifying oral carcinogenesis based on feature extraction for gray-level co-occurrence matrix using scanned laser pico projector.
    Lian MJ; Huang CL; Lee TM
    Lasers Med Sci; 2022 Feb; 37(1):215-224. PubMed ID: 33528670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.